fda warning letters bpc-157 2023 Approval Status: Is It Approved for Human Use? FDA Warning Letter to Stuart
Description
Works locally at the injection site
doi: 10.1093/geront/gnaf223 [DOI] [PMC free article] [PubMed] [Google Scholar] 732
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling
Clinical Features Patients will present with sudden onset pain and weakness * at the affected area
